Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five ...

and now certain breast cancer patients can benefit from the drug on the NHS. “It’s fantastic news that olaparib has been approved for use on the NHS in England, providing a second targeted ...

The NHS is launching the world's largest artificial intelligence trial for breast cancer detection - which is set to analyse ...

Prostate cancer has become England's most common cancer, overtaking breast cancer in 2022 and 2023, according to new analysis ...

Alarming statistics show there has been a rise in secondary breast cancer and according to a study of NHS admissions in 2021, it's estimated there are around 57,000 women in the UK living with the ...

It was my worst nightmare.' Hannah is one of an estimated 57,000 women in the UK living with secondary breast cancer, according to a study of NHS admissions in 2021 – a figure that's been rising ...

Ms Mansell, 29, from Port Talbot, waited nearly eight months for a referral when she found a dimple in her breast in ... as the same NHS services are required to tackle cancer delays and lengthy ...

Analysis of NHS data by Prostate Cancer UK found 50,751 men were diagnosed with prostate cancer in England in 2022 compared with 48,531 diagnoses of breast cancer. The figures increased again in 2023, ...